Here's the live share price of Abbott India along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Abbott India has gained 13.33% CAGR. Over the past year, the corresponding return has been 0.08%.
Abbott India’s current P/E of 42.43x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Abbott India | -3.15 | -2.92 | -15.75 | -5.70 | 0.08 | 14.62 | 13.33 |
| Sun Pharmaceutical Industries | -0.57 | 3.28 | -0.92 | -7.60 | -8.61 | 18.48 | 29.21 |
| Divi's Laboratories | 2.65 | 18.41 | 2.45 | 10.85 | 14.73 | 23.31 | 17.28 |
| Cipla | -5.18 | -0.81 | -3.38 | -1.58 | -3.32 | 8.79 | 14.87 |
| Torrent Pharmaceuticals | -0.80 | -0.38 | -5.14 | 9.01 | 10.85 | 29.10 | 22.78 |
| Dr. Reddy's Laboratories | -6.61 | -3.78 | -5.65 | 1.37 | -5.90 | 10.60 | 4.30 |
| Mankind Pharma | -2.15 | -2.43 | -7.34 | -0.11 | -10.77 | 18.66 | 10.81 |
| Zydus Lifesciences | -3.15 | -1.79 | 0.41 | 10.00 | -2.78 | 30.95 | 18.88 |
| Lupin | 1.95 | -0.64 | 2.09 | -4.31 | -9.93 | 41.27 | 16.64 |
| Aurobindo Pharma | 4.93 | 4.74 | -0.20 | -6.06 | -18.43 | 28.36 | 8.42 |
| Alkem Laboratories | -0.73 | 0.83 | 9.42 | 8.53 | -4.81 | 20.39 | 15.68 |
| Glenmark Pharmaceuticals | 3.96 | -3.48 | -11.38 | 37.43 | 11.65 | 67.21 | 31.92 |
| Laurus Labs | 3.16 | 9.45 | 9.18 | 53.86 | 94.04 | 28.05 | 25.98 |
| Biocon | 3.58 | 7.36 | -4.88 | 16.74 | 17.67 | 11.37 | -1.64 |
| GlaxoSmithKline Pharmaceuticals | -4.58 | -2.61 | -16.91 | -8.00 | -3.51 | 23.97 | 13.24 |
| Anthem Biosciences | -1.31 | -7.94 | -6.37 | -2.73 | -2.73 | -0.92 | -0.55 |
| Ipca Laboratories | 0.17 | -4.35 | -13.80 | -7.87 | -20.02 | 11.98 | 2.00 |
| Gland Pharma | -0.60 | -2.66 | -6.66 | 37.25 | 16.79 | 2.61 | 1.15 |
| Ajanta Pharma | 2.22 | 2.85 | -10.32 | -4.54 | -19.69 | 23.86 | 18.63 |
| Cohance Lifesciences | -14.14 | -13.44 | -24.49 | -33.68 | -42.74 | 23.71 | 20.22 |
Over the last one year, Abbott India has gained 0.08% compared to peers like Sun Pharmaceutical Industries (-8.61%), Divi's Laboratories (14.73%), Cipla (-3.32%). From a 5 year perspective, Abbott India has underperformed peers relative to Sun Pharmaceutical Industries (29.21%) and Divi's Laboratories (17.28%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 29,975.83 | 29,760.79 |
| 10 | 29,931.7 | 29,835.97 |
| 20 | 29,880.9 | 29,973.95 |
| 50 | 30,800.79 | 30,636.63 |
| 100 | 32,068.59 | 31,077.78 |
| 200 | 30,811.53 | 30,719.29 |
In the latest quarter, Abbott India remained same as its previous close in promoter holding, while DII stake decreased to 9.11%, FII holding unchanged at 0.16%, and public shareholding moved up to 15.74% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 2,74,878 | 2.36 | 805.12 | |
| 1,66,043 | 1.56 | 486.34 | |
| 1,44,836 | 1.66 | 424.22 | |
| 87,483 | 0.54 | 256.24 | |
| 80,000 | 3.99 | 234.32 | |
| 74,300 | 1.92 | 217.62 | |
| 68,677 | 2.48 | 201.15 | |
| 52,304 | 1.25 | 153.2 | |
| 40,000 | 2.98 | 117.16 | |
| 32,022 | 0.7 | 93.79 |
* Excluding Index & Arbitrage Funds
| Price | (%) As on Invalid Date IST |
| Open Interest | (%) |
| High | |
| Low | |
| Open | |
| Close | |
| Contract Traded | |
| Turnover (in lakhs) |
Date Time | Announcement |
|---|---|
| Oct 29, 2025, 9:03 PM IST | Abbott India Ltd. - Board Meeting Intimation for Intimation Under Regulation 29(1)(A) Of The Securities And Exchange Board Of |
| Oct 15, 2025, 8:50 PM IST | Abbott India Ltd. - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report |
| Oct 13, 2025, 7:55 PM IST | Abbott India Ltd. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Oct 08, 2025, 9:08 PM IST | Abbott India Ltd. - Announcement under Regulation 30 (LODR)-Change in Management |
| Sep 25, 2025, 4:47 PM IST | Abbott India Ltd. - Announcement under Regulation 30 (LODR)-Change in Management |
Abbott India Ltd. is a Public Limited Listed company incorporated on 22/08/1944 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24239MH1944PLC007330 and registration number is 007330. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 6409.15 Cr. and Equity Capital is Rs. 21.25 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Abbott India is ₹29,000.00 as on Oct 31, 2025.
The Abbott India is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.
The market cap of Abbott India is ₹61,622.98 Cr as on Oct 31, 2025.
Today’s highest and lowest price of Abbott India are ₹29,645.00 and ₹28,955.05.
The 52-week high/low is the highest and lowest price at which Abbott India stock has traded in the past 52-week or nearly a year. The 52-week high of Abbott India is ₹35,921.55 and 52-week low of Abbott India is ₹25,260.20 as on Oct 31, 2025.
The Abbott India has shown returns of -2.14% over the past day, -2.92% for the past month, -15.75% over 3 months, 0.08% over 1 year, 14.62% across 3 years, and 13.33% over 5 years.
P/E ratio of and PB ratio of Abbott India are 42.43 and 14.56 on Oct 31, 2025. While the company gives a dividend yield of 1.64 per annum.